A nurse is reinforcing teaching to a client who has long-term symptoms of GERD. Which of the following statements should the nurse include in the education?

Brief Introduction: Long-term gastroesophageal reflux disease (GERD) exposes the esophageal squamous epithelium to chronic acid injury, leading to metaplastic changes. This condition, known as Barrett's esophagus, involves the replacement of normal esophageal lining with specialized columnar epithelium, which serves as a precursor to esophageal adenocarcinoma. Rationale: A. There is no established pathophysiological link between GERD and the development of pancreatic cancer. Pancreatic malignancy is primarily associated with risk factors such as chronic pancreatitis, smoking, and specific genetic mutations, rather than the retrograde flow of gastric acid into the esophagus. B. GERD is a structural and mechanical disorder of the lower esophageal sphincter and does not impact the endocrine function of the pancreas or insulin sensitivity. Obesity is a shared risk factor for both GERD and type 2 diabetes, but the reflux itself does not increase the risk of developing metabolic disorders. C. Chronic acid exposure can cause the esophageal lining to undergo intestinal metaplasia to better withstand the low pH of gastric contents. Because this tissue change significantly increases the risk of malignancy, clients with long-term symptoms require regular endoscopic surveillance and biopsies by a gastroenterologist to detect precancerous cells early. D. GERD is localized to the upper gastrointestinal tract and does not impair hepatic function or lead to liver disease. Although some medications used to treat GERD (like Proton Pump Inhibitors) are metabolized by the liver, the disease process itself does not necessitate monitoring for hepatotoxicity or jaundice.